» Authors » Suresh Giri

Suresh Giri

Explore the profile of Suresh Giri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 117
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giri S, Sharma S, Mahyavanshi R, Kalita G, Yang Y, Tanemura M
Nanomaterials (Basel) . 2025 Jan; 15(2). PMID: 39852729
We present a versatile method for synthesizing high-quality molybdenum disulfide (MoS) crystals on graphite foil edges via chemical vapor deposition (CVD). This results in MoS/graphene heterostructures with precise epitaxial layers...
2.
Srinivas A, Suresh D, Suvarna D, Pathak P, Giri S, Suman , et al.
Int J Mol Sci . 2023 Feb; 24(4). PMID: 36834657
The pathophysiology of nonalcoholic steatohepatitis (NASH) is complex, owing to its diverse pathological drivers and, until recently, there were no approved drugs for this disease. is a popular herbal medicine...
3.
Yadav P, Kumar S, Agarwal K, Jain M, Patil D, Maithal K, et al.
J Med Virol . 2023 Jan; 95(2):e28484. PMID: 36625386
The apprehension of needles related to injection site pain, risk of transmitting bloodborne pathogens, and effective mass immunization have led to the development of a needle-free injection system (NFIS). Here,...
4.
Yadav P, Mendiratta S, Mohandas S, Singh A, Abraham P, Shete A, et al.
Viruses . 2021 Dec; 13(12). PMID: 34960695
We have developed a monoclonal antibody (mAb) cocktail (ZRC-3308) comprising of ZRC3308-A7 and ZRC3308-B10 in the ratio 1:1 for COVID-19 treatment. The mAbs were designed to have reduced immune effector...
5.
Pola S, Shah S, Pingali H, Zaware P, Thube B, Makadia P, et al.
Bioorg Med Chem . 2021 Feb; 35:116071. PMID: 33611013
The ever-growing prevalence of Type-2 diabetes in the world has an urgent need for multiple orally effective agents that can regulate glucose homeostasis. G-Protein coupled receptor 119 (GPR 119) agonists...
6.
Agarwal S, Sasane S, Kumar J, Deshmukh P, Bhayani H, Giri P, et al.
Bioorg Med Chem Lett . 2018 Apr; 28(10):1849-1852. PMID: 29655980
TGR5 is a member of G protein-coupled receptor (GPCR) superfamily, a promising molecular target for metabolic diseases. Activation of TGR5 promotes secretion of glucagon-like peptide-1 (GLP-1), which activates insulin secretion....
7.
Das N, Mandala A, Naaz S, Giri S, Jain M, Bandyopadhyay D, et al.
J Pineal Res . 2017 Mar; 62(4). PMID: 28247434
Lipid generates reactive oxygen species (ROS) in consequence to mitochondrial fission followed by inflammation in propagating hepatic fibrosis. The interaction of SIRT1/Mitofusin2 is critical for maintaining mitochondrial integrity and functioning,...
8.
Agarwal S, Sasane S, Deshmukh P, Rami B, Bandyopadhyay D, Giri P, et al.
ACS Med Chem Lett . 2016 Dec; 7(12):1134-1138. PMID: 27994752
GPR40/FFAR1 is a G protein-coupled receptor predominantly expressed in pancreatic β-cells and activated by long-chain free fatty acids, mediating enhancement of glucose-stimulated insulin secretion. A novel series of substituted 3-(4-aryloxyaryl)propanoic...
9.
Agarwal S, Patil A, Aware U, Deshmukh P, Darji B, Sasane S, et al.
ACS Med Chem Lett . 2016 Jan; 7(1):51-5. PMID: 26819665
TGR5 is a G protein-coupled receptor (GPCR), activation of which promotes secretion of glucagon-like peptide-1 (GLP-1) and modulates insulin secretion. The 2-thio-imidazole derivative 6g was identified as a novel, potent,...
10.
Raval P, Jain M, Goswami A, Basu S, Gite A, Godha A, et al.
Bioorg Med Chem Lett . 2011 Apr; 21(10):3103-9. PMID: 21450468
In an effort to develop safe and efficacious compounds for the treatment of metabolic disorders, novel thiophene substituted oxazole containing α-alkoxy-phenylpropanoic acid derivatives are designed as highly potent PPARα/γ dual...